A mGlu2/3 Agonist in the Treatment of PTSD

Clinical trial NCT02234687 · TERMINATED

Trial details

NCT number: NCT02234687
Sponsor: NYU Langone Health
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Post-traumatic Stress Disorder

Start date: 2014-09-01
Primary completion: 2016-02-11
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.